Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Change in Accured Expenses (2016 - 2017)

Historic Change in Accured Expenses for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $172693.0.

  • Tenax Therapeutics' Change in Accured Expenses fell 8591.86% to $172693.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$5.0 million, marking a year-over-year decrease of 36362.65%. This contributed to the annual value of $523000.0 for FY2024, which is 12067.51% up from last year.
  • According to the latest figures from Q4 2017, Tenax Therapeutics' Change in Accured Expenses is $172693.0, which was down 8591.86% from -$1.3 million recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Change in Accured Expenses registered a high of $2.1 million during Q1 2013, and its lowest value of -$2.9 million during Q2 2017.
  • Moreover, its 5-year median value for Change in Accured Expenses was $125641.5 (2014), whereas its average is $219968.7.
  • As far as peak fluctuations go, Tenax Therapeutics' Change in Accured Expenses soared by 11106.69% in 2014, and later plummeted by 168332.1% in 2015.
  • Over the past 5 years, Tenax Therapeutics' Change in Accured Expenses (Quarter) stood at $1.3 million in 2013, then surged by 32.39% to $1.8 million in 2014, then tumbled by 170.79% to -$1.2 million in 2015, then soared by 198.56% to $1.2 million in 2016, then crashed by 85.92% to $172693.0 in 2017.
  • Its Change in Accured Expenses stands at $172693.0 for Q4 2017, versus -$1.3 million for Q3 2017 and -$2.9 million for Q2 2017.